Overview

Study of ZG005 in Combination With Paclitaxel＋Platinum-based ± Bevacizumab in Patients With Advanced Cervical Carcinoma

Status:
RECRUITING
Trial end date:
2026-05-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, open-label phase I/II study for the first-line treatment of advanced cervical cancer.
Phase:
PHASE1
Details
Lead Sponsor:
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Treatments:
Bevacizumab
Carboplatin
Cisplatin
Injections
Paclitaxel